Loading data for BLSM — first visit, this takes a few seconds.
BlossomHill Therapeutics ... (BLSM)
NasdaqGS: BLSM
· リアルタイム株価 · USD
16.10
-0.28 (-1.71%)
終値時点: Aug 18, 2026, 8:00 PM
BlossomHill Therapeutics Inc. (BLSM) Stock Price, Analysis & Data
-1.71% (1D)
データがありません
BLSMについて
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (...
セクター Healthcare
IPO日 Aug 7, 2026
従業員数 63
上場取引所 NasdaqGS
ティッカー BLSM
ウェブサイト https://bhtherapeutics.com
